http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021130672-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f5dfc0eed1db83b989cce292d784356
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 2021-05-07^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd7107d1a497647c4b670e2b43b9e75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a9a9b61431d1e4badcf61fa0e5c999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9de0c84f8a52b36a67fe8f36fced10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdaae4738bc8c1a026c8f48976dcbd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436d566d170404160975d264669f2756
publicationDate 2021-09-09^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021130672-A
titleOfInvention Bicyclic peptide ligand specific for MT1-MMP
abstract PROBLEM TO BE SOLVED: To provide a drug conjugate containing a peptide which is a high affinity binder of a membrane type 1 metalloprotease (MT1-MMP). A peptide ligand specific for MT1-MMP, a polypeptide containing at least three cysteine residues separated by at least two loop sequences, and a molecule that forms a covalent bond with the cysteine residue of the polypeptide. It contains TBMB, which is a scaffold, so that at least two polypeptide loops are formed on the molecular scaffold, and the peptide ligand is the amino acid sequence: βAla-Sar10-AC (D-Ala) NE (1Nal) (D-Ala). ) Provide a drug conjugate comprising CEDFYD (tBuGly) C or a pharmaceutically acceptable salt thereof. [Selection diagram] None
priorityDate 2014-10-29^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013518807-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013518558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014528245-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468096093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160065362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467881895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465084763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451552006

Showing number of triples: 1 to 39 of 39.